Prostate cancer and radiation
Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. More than 99 percent of prostate cancers develop in the gland cells. This type of prostate cancer is called adenocarcinoma. Prostate cancer is a highly treatable disease, especially if caught early.
You can find additional information on prostate cancer on our Cancer Resources page.
Information on this page was resourced from:
About prostate cancer
Prostate cancer is the most common cancer among men (after skin cancer), but it can often be treated successfully. More than 99 percent of prostate cancers develop in the gland cells. This type of prostate cancer is called adenocarcinoma. Prostate cancer usually grows very slowly.
When radiation therapy is a treatment option for you, our MRO care team will work in close collaboration with your oncology care team. The radiation oncology specialists at MRO will recommend a treatment plan providing the information patients and their families need to be fully informed about their prostate cancer and treatment options.
Prostate cancer forms in the tissues of the prostate gland, the male sex gland responsible for producing semen. Prostate cancer is a highly treatable disease, especially if caught early. Symptoms often do not develop until the cancer has progressed to more advanced stages, and when they do arise, they may mimic other, less serious conditions. Risk factors for prostate cancer include age, family history, and a high-fat diet.
Radiation treatment options
Radiation treatment for prostate cancer requires accuracy and precision. With advanced radiation therapy delivery systems, our MRO radiation oncologists are better able to target difficult-to-reach tumors involving the prostate, and we can also direct higher radiation doses at prostate cancer cells while reducing exposure to normal, healthy tissue.
We offer two primary types of radiation therapy for the treatment of prostate cancer:
External beam radiation therapy (EBRT): Delivers high doses of radiation to prostate cancer cells from outside the body, using a variety of machine-based technologies.
Low-dose rate (LDR) brachytherapy (internal radiation): Delivers high doses of radiation from permanent seed implants placed inside the prostate.